Prakash Javadekar who is the Union Minister said on 2nd January, Saturday that India has given the signal and also a green light to the Covid-19 vaccine that was developed and made by the Oxford University- which is named as the AstraZeneca and also the three other vaccine candidates are now waiting for the emergency use of the authorisation.
The sources had also told on 1st January, Friday that the subject expert committee of the Indian drug regulator had also cleared the decks for the Covishield which is the the Indian name of the Oxford vaccine and which will be used in emergency in our country.
The Sources had also said that the recommendations of the SEC comes with certain conditions. Every recipient who will be getting the vaccine will also be given a factsheet about the vaccine before they receive their vaccination.
The manufacturer can also ask them to report their adverse event after every 15 days. The SEC has also recommended the EUA to give the two full doses and that also with a gap of atleast 4-6 days.
The General of the Drugs Controller of India is also left to formally announce the approval. Covishield is the first coronavirus vaccine that will be approved for the emergency uses in our country India. Our country is the one which has the highest number of infections after the United States.
Javadekar had also said that at least three more vaccines are still on it’s way to be approved.
He said that India is perhaps the only country in the whole world where not only one but where at least four different vaccines for COVID are getting ready.
He said that one of them was approved yesterday for the time of emergency use. He said that referring to the fact that the AstraZeneca shot is being made in our country locally by the Serum Institute of India.
Serum Institution of India is the biggest producer of the vaccine in the world and that it has already stockpiled a total of about 50 million doses of the are the Oxford shot.
The vaccine made by the Oxford was granted and was given it’s first approval by Britain in this week on Tuesday, it is cheaper and also it is a lot easier to use than some of the rival and simple shots.
However, it has caused trouble with the uncertainty about its most effective dosage ever since the data was published in the month of November and that it had also showed a half-dose that was then followed by a full dose which had a 90% success rate while the other two full shots were only 62% effective.
The regulator of India has also received an emergency-use of the application for the Covid-19 vaccine which was made by the Pfizer Inc company along with the BioNTech company of Germany – which is the first shot to secure a regulatory approval in the West.
At the same time, a nationwide dry run to get the access of the preparedness on field for the process of the vaccination was also conducted on Saturday.
The exercise was conducted in all the capitals of the state and also at least ibn Today, Harsh Vardhan who is the Union health minister said that the vaccines of the Covid-19 will also be provided to all the Indians for free.